Hearing Loss Trial, Recruiting NCT06664697 Sponsor: iotaMotion, Inc. Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT06664697
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a type of hearing loss caused by damage to the inner ear or hearing nerve (called sensorineural hearing loss) and have already received, or are planned to receive, a cochlear implant in one or both ears using one of these specific FDA-approved devices: Advanced Bionics HiFocus SlimJ, Cochlear Slim Straight, or MED-EL Flex 24 and 28.
  • People who are 12 years of age or older at the time of their cochlear implant surgery.
  • People who are willing to take part in the study and are able to attend the required follow-up visits.

Who may not be able to join:

  • People who have previously had a cochlear implant in the ear that is being considered for implantation in this trial.
  • People whose inner ear has hardening of tissue (ossification) or other structural changes that could prevent the implant from being fully inserted, or that increase the risk of the device being placed incorrectly.
  • People who have certain physical differences in their skull or face structure, a skull that is too thin in a specific area (less than 3mm), significant changes inside the inner ear such as scarring or fractures, or abnormal inner ear development.
  • People whose hearing loss is caused by damage to the hearing nerve itself or to hearing pathways in the brain, rather than the inner ear.
  • People who have been diagnosed with auditory neuropathy (a specific condition affecting how sound signals travel from the ear to the brain).
  • People who have an active infection in the middle ear, or a hole in the eardrum alongside an active middle ear infection.
  • People who were born without a developed inner ear (cochlea).
  • People who have other health concerns that the trial doctor determines would prevent them from completing the required assessments.
  • People who have unrealistic expectations about what the cochlear implant procedure and this trial's investigational device can and cannot do.
  • People whose first language is not English and who are unable to read, understand, or speak English well enough to complete the required study procedures.
  • People who are currently taking part in, or planning to take part in, another clinical study involving an investigational device or drug.
  • People who meet the definition of a "vulnerable subject" under U.S. federal research regulations (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 442-325-4171

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
iotaMotion, Inc.
Registry
ClinicalTrials.gov
Start date
1 October 2024
Est. completion
31 October 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of Subjects Experiencing a Serious or Related Adverse Event Due to Use of the iotaSOFT Insertion System During Cochlear Implant Surgery

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov